MRKR Chart
- 52-Week Range: $0.31 - $3.56
- Market Capitalization: $29.58M
- Short Percentage: 0%
- Target Price: $3.38
- Shares Outstanding: 83.08M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
MRKR released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Marker Therapeutics Reports Fiscal Year 2021 Operating and Financial ResultsGlobeNewsWire | March 17th
- Marker Therapeutics to Present at Two Upcoming March Investor ConferencesGlobeNewsWire | March 7th
- Marker Therapeutics Announces Clinical Program Updates and Pipeline ExpansionGlobeNewsWire | February 16th
- Marker Therapeutics Appoints Biotech Executive Katharine Knobil, M.D., to Board of DirectorsPRNewsWire | December 9th
- Marker Therapeutics Reports Third Quarter 2021 Operating and Financial ResultsPRNewsWire | November 10th
- Marker Therapeutics Secures $13.1M Grant To Support MultiTAA Cell Therapy TrialBenzinga | August 20th
Company Info
Website: https://www.markertherapeutics.com
Address: 3200 Southwest Freeway, Houston, TX, United States, 77027
Sector: Healthcare
Industry: Biotechnology
Full time employees: 56
Address: 3200 Southwest Freeway, Houston, TX, United States, 77027
Sector: Healthcare
Industry: Biotechnology
Full time employees: 56
$MRKR Many many bears
$MRKR BOUGHT TODAY!
$MRKR Going up
$MRKR doesn’t look good for Monday.
$MRKR bull here. But I’m worried for tomorrow
$MRKR starting to gap up a little
$MRKR FYI - leaning bullish
$MRKR might get a sell off today
$MRKR how long until we take off?
$MRKR man this will be good in coming weeks